A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin [Corrigendum]

This article refers to:

A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin

Kerob D, Czermanska A, Karamon EM, et al. Clin Cosmet Investig Dermatol. 2023;16:1787–1794.

The authors have advised Figure 5b on page 1792 is incorrect. Due to an error that occurred inadvertently at the time of figure assembly, figure part b was duplicated from part a. The correct Figure 5 is shown below.

Figure 5 Biomarkers at Day 0 and Day 14. (a) Interleukin 1α. (b) Interleukin-1-receptor antagonist. (c) Prostaglandin E2. Differences from Day 0 were statistically significant (*p<0.0001) for all 3 biomarkers after 14 days of daily use.

The authors apologize for this error and advise it does not affect the results of the paper.